Precision Optics Corporation, Inc. Announces Operating Results for the Fourth Quarter and Fiscal Year Ended June 30, 2016

GARDNER, Mass., Sept. 28, 2016 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30, 2016.

Fourth quarter highlights include:

  • Revenues of $963 thousand in the fourth quarters of fiscal 2016 and 2015;
  • 87% year-over-year increase in quarterly engineering service revenue;
  • 51% year-over-year increase in quarterly gross profit, with gross margin of 33.2% compared to 21.9%;
  • Continued progress toward conversion of engineering projects to production orders.

Fiscal year highlights include:

  • Continuation of revenues at their highest levels over the last eleven years at $3.9 million for each of fiscal years 2016 and 2015;
  • 124% year-over-year increase in annual engineering service revenue in fiscal 2016 versus 2015;
  • 18% year-over-year increase in annual gross profit, with gross margin of 24.1% in fiscal 2016 compared to 20.4% in 2015;
  • 12% year-over-year decrease in annual net loss in fiscal 2016 versus 2015 with similar revenue.

Precision Optics’ CEO, Joseph Forkey, commented, “While revenues for the fourth fiscal quarter and for the fiscal year were flat when compared to fiscal 2015, we are excited about the product mix of our revenues in fiscal 2016 and the change that it represents. Revenue generated from our engineering services increased nearly eight hundred thousand dollars during fiscal 2016. We believe we are seeing the growing acceptance of and demand for our unique technologies and products. We are excited about the impact our products and services are having on our customers’ medical device initiatives, and the effects that success can have on the expansion of our business and financial performance in the near and long term."

Dr. Forkey continued, “We are also pleased to see improvements in our operational efficiency and financial performance, as reflected in improved gross margin and lower net losses. These improvements are driven, in part, by the change in product mix to include more engineering service work. However, it is also indicative of the progress we have made in transitioning our Microprecision™ technologies from use in small volume prototype applications to larger volume production. While this transition does not happen quickly, we are clearly seeing the effects of greater efficiency as we gain more and more experience with these new technologies in a production environment. We expect some variation in margins as we continue to bring new products into production but expect, over time, gross margins and overall profits as a percent of revenue to increase as these efficiencies continue to grow, and as we continue to absorb fixed expenses across a higher revenue base.”

The following table summarizes the fourth quarter and year results for the periods ended June 30, 2016 and 2015 (unaudited):

Three Months
Ended June 30,
Ended June 30,
2016 2015 2016 2015
Revenues $962,678 $962,906 $3,916,702 $3,912,060
Gross Profit 319,128 210,692 942,021 798,271
Operating Expenses 467,684 568,977 1,997,455 2,011,324
Operating Loss (148,556) (358,285) (1,055,434) (1,213,053)
Net Loss (149,468) (363,247) (1,034,765) (1,178,793)
Loss Per Share:
Basic $(0.02) $(0.06) $(0.15) $(0.19)
Diluted $(0.02) $(0.06) $(0.15) $(0.19)
Weighted Average Common Shares Outstanding:
Basic and Diluted 7,539,582 6,355,142 7,157,978 6,272,264

Quarterly Conference Call Details
The Company has scheduled a conference call to discuss the fiscal fourth quarter 2016 financial results for Thursday, September 29, 2016 at 9:00 AM Eastern. To participate in the conference call, please dial 1-866-652-5200 toll free from the U.S., or 1-412-317-6060 from outside the U.S., and ask to be connected to the Precision Optics, Corp. conference call.

An audio replay of the conference call will be available approximately one hour after the conclusion of the call and will be made available until October 13, 2016. The audio replay can be accessed toll free by dialing 1-877-344-7529 from the U.S., or 1-412-317-0088 from outside the U.S., or 1-855-669-9658 from Canada, and entering Replay Access Code 10093345.

About Precision Optics Corporation
Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982. Using proprietary optical technologies, the Company designs and produces next generation medical instruments, MicroprecisionTM micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems for a broad range of customers including some of the largest global medical device companies. The Company’s innovative medical instrumentation line includes state-of-the-art endoscopes and endocouplers as well as custom illumination and imaging products for use in minimally invasive surgical procedures. The Company believes that current advances in its proprietary micro-optics and 3D imaging technologies present significant opportunities for expanding applications to numerous potential medical products and procedures. The Company’s website is Investors can find Real-Time Quotes and market information for the Company on .

About Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements include, but are not limited to, statements that express the Company’s intentions, beliefs, expectations, strategies, predictions or any other statements related to the Company’s future activities or future events or conditions. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by the Company’s management. These statements are not guarantees of future performances and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in the Company’s annual report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this report, except as required by law.

Following are the Company’s Consolidated Balance Sheets at June 30, 2016 and June 30, 2015, and Statements of Operations for the years ended June 30, 2016 and 2015 and Statements of Cash Flows for the years ended June 30, 2016 and 2015:

2016 2015
Current Assets:
Cash and cash equivalents $50,059 $241,051
Accounts receivable (net of allowance for doubtful accounts of $23,377 in 2016 and 2015) 750,380 588,042
Inventories 1,133,451 1,073,256
Prepaid expenses 88,129 65,182
Total current assets 2,022,019 1,967,531
Fixed Assets:
Machinery and equipment 2,479,471 2,431,127
Leasehold improvements 553,596 553,596
Furniture and fixtures 148,303 148,303
Vehicles 19,674 19,674
3,201,044 3,152,700
Less—Accumulated depreciation and amortization 3,122,849 3,096,993
Net fixed assets 78,195 55,707
Patents, net 22,874 18,644
$2,123,088 $2,041,882
Current Liabilities:
Current portion of capital lease obligation $7,857 $
Accounts payable 1,151,561 912,150
Customer advances 118,800
Accrued employee compensation 238,381 222,222
Accrued professional services 65,550 60,735
Accrued warranty expense 25,000 25,000
Other accrued liabilities 15,612 36,087
Total current liabilities 1,503,961 1,374,994
Capital lease obligation, net of current portion 31,955
Commitments (Note 2)
Stockholders’ Equity:
Common stock, $0.01 par value: 50,000,000 shares authorized; issued and outstanding –
7,539,582 shares at June 30, 2016 and 6,389,806 shares at June 30, 2015 75,396 63,898
Additional paid-in capital 44,176,051 43,232,500
Accumulated deficit (43,664,275) (42,629,510)
Total stockholders’ equity 587,172 666,888
$2,123,088 $2,041,882

2016 2015
Revenues $ 3,916,702 $3,912,060
Cost of goods sold 2,974,681 3,113,789
Gross profit 942,021 798,271
Research and development expenses, net 478,267 492,937
Selling, general and administrative expenses 1,551,895 1,545,462
Gain on sale of assets (32,707) (27,075)
Total operating expenses 1,997,455 2,011,324
Operating loss (1,055,434) (1,213,053)
Interest expense (469)
Other income 22,050 35,172
Loss before provision for income taxes (1,033,853) (1,177,881)
Provision for income taxes 912 912
Net loss $ (1,034,765) $(1,178,793)
Loss per share:
Basic $ (0.15) $(0.19)
Diluted $ (0.15) $(0.19)
Weighted average common shares outstanding:
Basic 7,157,978 6,272,264
Diluted 7,157,978 6,272,264

2016 2015
Cash Flows from Operating Activities:
Net loss $ (1,034,765) $(1,178,793)
Adjustments to reconcile net loss to net cash used in operating activities-
Depreciation and amortization 25,856 21,271
Gain on sale of assets (32,707) (27,075)
Stock-based compensation expense 241,388 125,675
Non-cash consulting expense 63,000 66,750
Non-cash gain on settlement of liabilities by issuing common stock (22,050) (35,172)
Changes in operating assets and liabilities-
Accounts receivable, net (162,338) (56,993)
Inventories (60,195) (84,378)
Prepaid expenses (22,947) 26,740
Accounts payable 261,461 210,958
Customer advances (118,800) 92,600
Accrued expenses (14,201) 64,624
Net cash used in operating activities (876,298) (773,793)
Cash Flows from Investing Activities:
Proceeds from sale of assets 32,707 27,075
Additional patent costs (4,230) (10,972)
Purchases of fixed assets (4,372) (62,418)
Net cash provided by (used in) investing activities 24,105 (46,315)
Cash Flows from Financing Activities:
Payment of capital lease obligation (4,160) -
Proceeds from private placements of common stock 700,000 980,291
Private placement expenses incurred and paid as of June 30, 2016 and 2015 (34,639) (121,512)
Net cash provided by financing activities 661,201 858,779
Net (decrease) increase in cash and cash equivalents (190,992) 38,671
Cash and cash equivalents, beginning of year 241,051 202,380
Cash and cash equivalents, end of year $ 50,059 $241,051
Supplemental disclosure of cash flow information:
Cash paid during the year for income taxes $ 912 $912
Issuance of 105,000 and 217,520 shares of common stock for services rendered to
the company in fiscal year 2016 and 2015, respectively
$ 48,300 $126,643
Private placement expenses incurred but not yet paid $ 37,781 $6,000
Capital expenditures funded by capital lease borrowings $ 43,972 $-

Company Contact: PRECISION OPTICS CORPORATION 22 EAST BROADWAY GARDNER, MASSACHUSETTS 01440-3338 Telephone: 978 -630-1800 Investor Contact: Kirin M. Smith, Chief Operating Officer PCG Advisory Group D: 646.863.6519 E:

Source:Precision Optics Corporation